Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7772209
(Pediatric) | LILLY | Antifolate combination therapies |
May, 2022
(10 months ago) |
Drugs and Companies using PEMETREXED DISODIUM ingredient
Market Authorisation Date: 04 February, 2004
Treatment: NA
Dosage: POWDER;INTRAVENOUS
Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7517334 | LILLY | Medication dispensing apparatus with spring-driven locking feature enabled by administration of final dose |
Mar, 2025
(1 year, 11 months from now) |
Drugs and Companies using TERIPARATIDE ingredient
Market Authorisation Date: 26 November, 2002
Treatment: NA
Dosage: SOLUTION;SUBCUTANEOUS
6
United States
2
Denmark
2
Portugal
2
Spain
2
Japan
2
European Union
1
Israel
1
South Africa
1
Austria
1
Mexico
1
Australia
1
Slovenia
1
Lithuania
1
Hungary
1
Norway
1
Croatia
1
Brazil
1
Korea, Republic of
1
Poland
1
RS
1
China
1
EA
1
Canada
1
New Zealand
1
ME
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic